ATH alterity therapeutics limited

Ann: Appendix 4E Preliminary Final Report, page-4

  1. 141 Posts.
    lightbulb Created with Sketch. 18
    I think its all absolutely fine. They are in the business end of a RCT that's fully enrolled with a number of patients already through the 12 month assessment. They have spent lots on r+d but what else would one expect.

    roughly 6M coming in 2025 through R+D rebate.

    its all about the q1 2025 readout. Boom or bust
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $100.4M
Open High Low Value Volume
1.0¢ 1.1¢ 1.0¢ $33.74K 3.068M

Buyers (Bids)

No. Vol. Price($)
38 12200722 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 17331619 7
View Market Depth
Last trade - 12.55pm 16/06/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.